KISS. Using Kaiku Health for symptom and QoL tracking of patients treated with immune checkpoint inhibitors targeting PD-1, PD-L1 and CTLA-4 antibodies
Patients are provided with the Kaiku Health web application to report on their symptoms and quality of life in real-time. Algorithms screen the patients’ symptom data and alert the care team according to the severity of symptoms. The study aims to unveil the impact of digital monitoring in managing immune-related adverse events, as well as patient compliance to the new follow-up method.